Literature DB >> 25692306

A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases the risk of papillary thyroid carcinoma.

Xunli Wang1, Hong Peng, Yundan Liang, Ruifen Sun, Tao Wei, Zhihui Li, Yanping Gong, Rixiang Gong, Feng Liu, Lin Zhang, Jingqiang Zhu.   

Abstract

This study aimed to assess whether an insertion/deletion polymorphic variation rs28362491 in the NFKB1 promoter region was related to the risk of papillary thyroid carcinoma (PTC). Genomic DNA was extracted from the peripheral venous blood of 352 patients with PTC and 459 controls. The NFKB1 rs28362491 polymorphism was genotyped by using a polymerase chain reaction assay. We found that the frequency of the heterozygous genotype ATTG1/ATTG2 was significantly higher in the cases compared to the controls (odds ratios [OR]=1.44, 95% confidence intervals [CI]=1.05-1.96, p=0.02). Moreover, the frequency of ATTG1/ATTG2+ATTG1/ATTG1 genotypes was significantly elevated in the cases compared to the controls (OR=1.38, 95% CI=1.03-1.85, p=0.03). These findings suggest that the -94 insertion/deletion ATTG polymorphism in the NFKB1 promoter might be associated with an increased risk of PTC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25692306      PMCID: PMC4361360          DOI: 10.1089/gtmb.2014.0271

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  54 in total

Review 1.  NF-kappaB: a key role in inflammatory diseases.

Authors:  P P Tak; G S Firestein
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

3.  Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis.

Authors:  Thomas J Giordano; Rork Kuick; Dafydd G Thomas; David E Misek; Michelle Vinco; Donita Sanders; Zhaowen Zhu; Raffaele Ciampi; Michael Roh; Kerby Shedden; Paul Gauger; Gerard Doherty; Norman W Thompson; Samir Hanash; Ronald J Koenig; Yuri E Nikiforov
Journal:  Oncogene       Date:  2005-10-06       Impact factor: 9.867

4.  Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.

Authors:  Chuan He Yang; Aruna Murti; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2005-07-11       Impact factor: 5.157

Review 5.  Thyroid cancer.

Authors:  O Gimm
Journal:  Cancer Lett       Date:  2001-02-26       Impact factor: 8.679

6.  Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.

Authors:  Bharat B Aggarwal; Shishir Shishodia; Yasunari Takada; Sanjeev Banerjee; Robert A Newman; Carlos E Bueso-Ramos; Janet E Price
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

7.  Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies.

Authors:  E Ron; J H Lubin; R E Shore; K Mabuchi; B Modan; L M Pottern; A B Schneider; M A Tucker; J D Boice
Journal:  Radiat Res       Date:  1995-03       Impact factor: 2.841

8.  Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.

Authors:  Yiwei Li; Fakhara Ahmed; Shadan Ali; Philip A Philip; Omer Kucuk; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

9.  Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas.

Authors:  Francesco Pacifico; Claudio Mauro; Ciro Barone; Elvira Crescenzi; Stefano Mellone; Mario Monaco; Gennaro Chiappetta; Giuseppe Terrazzano; Domenico Liguoro; Pasquale Vito; Eduardo Consiglio; Silvestro Formisano; Antonio Leonardi
Journal:  J Biol Chem       Date:  2004-10-08       Impact factor: 5.157

10.  Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.

Authors:  R Visconti; J Cerutti; S Battista; M Fedele; F Trapasso; K Zeki; M P Miano; F de Nigris; L Casalino; F Curcio; M Santoro; A Fusco
Journal:  Oncogene       Date:  1997-10-16       Impact factor: 9.867

View more
  8 in total

1.  Inherited variant in NFκB-1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding.

Authors:  Imene Hamadou; Sonia Garritano; Alessandro Romanel; Dalila Naimi; Talel Hammada; Francesca Demichelis
Journal:  Cancer Rep (Hoboken)       Date:  2020-02-20

2.  Association of IRAK1 Gene Polymorphism rs3027898 With Papillary Cancer Restricted to the Thyroid Gland: A Pilot Study.

Authors:  Anthoula Chatzikyriakidou; Angeliki Chorti; Theodosios Papavramidis
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

Review 3.  An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.

Authors:  Yi-Qiao Luo; Duan Wang; Teng Gong; Jiang Zhu
Journal:  Oncotarget       Date:  2016-09-06

4.  Nuclear factor-kappa B1 inhibits early apoptosis of glioma cells by promoting the expression of Bcl-2.

Authors:  Tian-Quan Yang; Min Chen; Yong-Qiang Wang; Wei Xu; Yong Han; Jin Xu; Yong-Jun Xiang; Bin Yuan; Hang-Zhou Wang; You-Xin Zhou
Journal:  Onco Targets Ther       Date:  2017-08-31       Impact factor: 4.147

Review 5.  NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.

Authors:  Wen Fu; Zhen-Jian Zhuo; Yung-Chang Chen; Jinhong Zhu; Zhang Zhao; Wei Jia; Jin-Hua Hu; Kai Fu; Shi-Bo Zhu; Jing He; Guo-Chang Liu
Journal:  Oncotarget       Date:  2017-02-07

Review 6.  Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.

Authors:  Vince Kornél Grolmusz; Anikó Bozsik; János Papp; Attila Patócs
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

7.  Genetic association between NFKB1 -94 ins/del ATTG Promoter Polymorphism and cancer risk: a meta-analysis of 42 case-control studies.

Authors:  Duan Wang; Tianhang Xie; Jin Xu; Haoyang Wang; Weinan Zeng; Shuquan Rao; Kai Zhou; Fuxing Pei; Zongke Zhou
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

Review 8.  NFKB1 and Cancer: Friend or Foe?

Authors:  Julia Concetti; Caroline L Wilson
Journal:  Cells       Date:  2018-09-07       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.